Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Total Current Liabilities: 2014-2025

Historic Total Current Liabilities for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Sep 2025 value amounting to $50.7 million.

  • Viridian Therapeutics, Inc.\DE's Total Current Liabilities rose 22.56% to $50.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.7 million, marking a year-over-year increase of 22.56%. This contributed to the annual value of $47.9 million for FY2024, which is 79.74% up from last year.
  • According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Total Current Liabilities is $50.7 million, which was down 3.59% from $52.6 million recorded in Q2 2025.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Total Current Liabilities peaked at $52.6 million during Q2 2025, and registered a low of $13.6 million during Q4 2021.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's median Total Current Liabilities value was $33.7 million (recorded in 2025), while the average stood at $36.1 million.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Total Current Liabilities spiked by 150.33% in 2021 and then fell by 20.13% in 2023.
  • Quarterly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Total Current Liabilities stood at $13.6 million in 2021, then surged by 144.57% to $33.3 million in 2022, then fell by 20.13% to $26.6 million in 2023, then skyrocketed by 79.74% to $47.9 million in 2024, then rose by 22.56% to $50.7 million in 2025.
  • Its Total Current Liabilities stands at $50.7 million for Q3 2025, versus $52.6 million for Q2 2025 and $33.7 million for Q1 2025.